These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32661688)
1. Laparoscopic Liver Resection for Hepatocellular Carcinoma in Child-Pugh A Patients With and Without Portal Hypertension: A Multicentre Study. Casellas-Robert M; Lim C; Lopez-Ben S; Lladó L; Salloum C; Codina-Font J; Comas-Cufí M; Ramos E; Figueras J; Azoulay D World J Surg; 2020 Nov; 44(11):3915-3922. PubMed ID: 32661688 [TBL] [Abstract][Full Text] [Related]
2. Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study. Lim C; Osseis M; Lahat E; Doussot A; Sotirov D; Hemery F; Lantéri-Minet M; Feray C; Salloum C; Azoulay D Surg Endosc; 2019 Mar; 33(3):811-820. PubMed ID: 30003350 [TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study. Zheng J; Feng X; Liang Y; Cai J; Shi Z; Kirih MA; Tao L; Liang X Surg Endosc; 2021 Jul; 35(7):3267-3278. PubMed ID: 32632488 [TBL] [Abstract][Full Text] [Related]
4. Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study. Molina V; Sampson-Dávila J; Ferrer J; Fondevila C; Díaz Del Gobbo R; Calatayud D; Bruix J; García-Valdecasas JC; Fuster J Surg Endosc; 2018 May; 32(5):2345-2354. PubMed ID: 29218665 [TBL] [Abstract][Full Text] [Related]
5. Impact and outcomes of liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension. Cortese S; Tellado JM Cir Cir; 2022; 90(5):579-587. PubMed ID: 36327469 [TBL] [Abstract][Full Text] [Related]
6. Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis. Chen X; Zhai J; Cai X; Zhang Y; Wei L; Shi L; Wu D; Shen F; Lau WY; Wu M Br J Surg; 2012 Dec; 99(12):1701-10. PubMed ID: 23132418 [TBL] [Abstract][Full Text] [Related]
7. Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach. Shinkawa H; Kaibori M; Kabata D; Nakai T; Ueno M; Hokuto D; Ikoma H; Iida H; Komeda K; Tanaka S; Kosaka H; Nobori C; Hayami S; Yasuda S; Morimura R; Mori H; Kagota S; Kubo S; Ishizawa T Surg Endosc; 2024 Feb; 38(2):757-768. PubMed ID: 38052887 [TBL] [Abstract][Full Text] [Related]
8. Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis. Xiang ZQ; Wu YC; Qu XL; Luo DJ; Liang H; Ameer S; Long ZT; Dai XM; Zhu Z World J Surg Oncol; 2024 Jan; 22(1):3. PubMed ID: 38166925 [TBL] [Abstract][Full Text] [Related]
9. Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma. Lopez-Lopez V; Brusadin R; López-Conesa A; Capel A; Navarro-Barrios Á; Cayuela V; Lopez-Banet E; Garzón-Arana A; Parrilla-Paricio P; Robles-Campos R Langenbecks Arch Surg; 2021 May; 406(3):763-771. PubMed ID: 33411038 [TBL] [Abstract][Full Text] [Related]
10. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study. Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182 [TBL] [Abstract][Full Text] [Related]
11. Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study. Memeo R; de'Angelis N; Compagnon P; Salloum C; Cherqui D; Laurent A; Azoulay D World J Surg; 2014 Nov; 38(11):2919-26. PubMed ID: 24912628 [TBL] [Abstract][Full Text] [Related]
12. Laparoscopic liver resections for hepatocellular carcinoma. Can we extend the surgical indication in cirrhotic patients? Cipriani F; Fantini C; Ratti F; Lauro R; Tranchart H; Halls M; Scuderi V; Barkhatov L; Edwin B; Troisi RI; Dagher I; Reggiani P; Belli G; Aldrighetti L; Abu Hilal M Surg Endosc; 2018 Feb; 32(2):617-626. PubMed ID: 28717870 [TBL] [Abstract][Full Text] [Related]
13. A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension. Ye JZ; Lu HZ; Zeng C; Lei G; Wang XB; Chen J; Bai T; Wu FX; Mai RY; Guo WX; Li LQ BMC Cancer; 2024 Jun; 24(1):764. PubMed ID: 38918786 [TBL] [Abstract][Full Text] [Related]
14. Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience. Coletta D; De Padua C; Parrino C; De Peppo V; Oddi A; Frigieri C; Grazi GL J Laparoendosc Adv Surg Tech A; 2020 Oct; 30(10):1054-1065. PubMed ID: 32707003 [No Abstract] [Full Text] [Related]
15. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation. Yu H; Zhao F; Men X; Zhu H; Yan J; Liu Z; Liu Q; Feng Y; Wang L; Meng M; Zhu Q; Zhao X Eur Radiol; 2024 May; 34(5):3226-3235. PubMed ID: 37875593 [TBL] [Abstract][Full Text] [Related]
16. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. Liu J; Zhang H; Xia Y; Yang T; Gao Y; Li J; Wu Y; Shen F HPB (Oxford); 2019 Jan; 21(1):1-13. PubMed ID: 30082213 [TBL] [Abstract][Full Text] [Related]
17. Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis. Di Sandro S; Bagnardi V; Najjar M; Buscemi V; Lauterio A; De Carlis R; Danieli M; Pinotti E; Benuzzi L; De Carlis L Surg Oncol; 2018 Dec; 27(4):722-729. PubMed ID: 30449499 [TBL] [Abstract][Full Text] [Related]
18. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F; Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354 [TBL] [Abstract][Full Text] [Related]
19. Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis. Guo ZY; Hong Y; Tu B; Cheng Y; Wang XM Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):358-365. PubMed ID: 35370090 [TBL] [Abstract][Full Text] [Related]
20. The value of liver stiffness measured by two-dimensional shear wave elastography for predicting symptomatic posthepatectomy liver failure in patients with hepatocellular carcinoma. Shi Y; Long H; Zhong X; Peng J; Su L; Duan Y; Ke W; Xie X; Lin M Eur J Radiol; 2022 May; 150():110248. PubMed ID: 35299113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]